Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
27 Results for "
poly(N-acryloyl succinimide)
" in MedChemExpress (MCE) Product Catalog:
Products (27)
27 Results for "poly(N-acryloyl succinimide)" in MCE Product Catalog:
2
Target:
Research Areas:
Phensuximide is an orally active succinimide antiepileptic and anticonvulsant agent. Phensuximide inhibits cyclic AMP and cyclic GMP accumulation in depolarized brain tissue. Phensuximide can be used for the study of seizure and petit mal .
1
Target:
Research Areas:
Methsuximide (Mesuximide) is an orally active succinimide-derived antiepileptic agent. Methsuximide interacts with cytochrome P-450, increases the level of hepatic microsomal cytochrome P-450, and inhibits or competes with the cytochrome P-450 CYP 2C9/10 subtype. Methsuximide can be used in epilepsy-related research .
Cat. No.: HY-79647
CAS No.: 82911-69-1
Synonyms: N-(Fmoc-oxy)succinimide
Category:
Target:
Cat. No.: HY-75200
CAS No.: 13139-17-8
Cat. No.: HY-P10355
CAS No.: 117756-27-1
Cat. No.: HY-178275
CAS No.: 2694026-77-0
Target:
Research Areas:
Hydrotecan-NH-L-Ala-L-Val-L-Gln (CO-C5-succinimide)-D-glucitol is a Drug-Linker Conjugates for ADC, which can be used in studies related to ADC synthesis, such as the anti-HER2 antibody-drug conjugate MB-3a. The toxin moiety of Hydrotecan-NH-L-Ala-L-Val-L-Gln (CO-C5-succinimide)-D-glucitol is Hydrotecan (HY-164378), and the linker moiety is Mc-Glu (D-Glucamine)-val-ala (HY-178309) .
Cat. No.: HY-148459
CAS No.: 2101204-23-1
Target:
Research Areas:
ATAC21, a linker-immune-stimulatory compound that can be formed by conjugating a noncleavable maleimide-PEG4 linker containing a succinimide group with an immune- stimulatory compound. ATAC21 can be combined with SBT-040 (anti-CD40 antibody) to form a conjugate .
Cat. No.: HY-D1352A
Cat. No.: HY-W160127
CAS No.: 5146-68-9
Synonyms: N-Methylolsuccinimide
Target:
Research Areas:
N-Hydroxymethyl succinimide (N-Methylolsuccinimide) is a promoiety used as a prodrug carrier for non-steroidal anti-inflammatory drugs (NSAIDs). N-Hydroxymethyl succinimide enhances the lipophilicity of NSAIDs and reducing the gastrointestinal toxicity of NSAIDs. N-Hydroxymethyl succinimide is promising for research of anti-inflammatory drug delivery system .
Cat. No.: HY-41877S
CAS No.: 32807-36-6
Cat. No.: HY-174289
CAS No.: 2408481-83-2
Target:
Research Areas:
TMTHSI succinimide NHS ester is a highly efficient cyclic alkyne click reagent. TMTHSI succinimide NHS ester has the primary activity to rapidly undergo strain-promoted cycloaddition reactions with azides. TMTHSI succinimide NHS ester is easily functionalized and can be linked to a variety of small molecules and (peptides, nucleic acids) biologics via a variety of linkers .
Cat. No.: HY-W744780
CAS No.: 160801-26-3
Target:
Research Areas:
Docosahexaenoic Acid N-Succinimide is the succinimide analog of Docosahexaenoic Acid. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules.
Cat. No.: HY-W097106
CAS No.: 60846-91-5
Target:
Research Areas:
(S)-3-N-Cbz-Amino-succinimide (Compound 1d) is an antiepileptic agent that can inhibit pentylenetetrazole (PTZ) and maximal electroshock (MES)-induced tonic convulsions in mice .
Research Areas:
Phensuximide (Standard) is the analytical standard of Phensuximide. This product is intended for research and analytical applications. Phensuximide is an orally active succinimide antiepileptic and anticonvulsant agent. Phensuximide inhibits cyclic AMP and cyclic GMP accumulation in depolarized brain tissue. Phensuximide can be used for the study of seizure and petit mal .
Cat. No.: HY-D1352
CAS No.: 1603861-95-5
Cat. No.: HY-132399S
CAS No.: 1189980-63-9
Research Areas:
Methsuximide-d5 is the deuterated-labeled Methsuximide (HY-B1376). Methsuximide (Mesuximide) is an orally active succinimide-derived antiepileptic agent. Methsuximide interacts with cytochrome P-450, increases the level of hepatic microsomal cytochrome P-450, and inhibits or competes with the cytochrome P-450 CYP 2C9/10 subtype. Methsuximide can be used in epilepsy-related research .
Target:
Research Areas:
Methsuximide (Standard) (Mesuximide (Standard); Celontin (Standard)) is the analytical standard of Methsuximide (HY-B1376). This product is intended for research and analytical applications. Methsuximide (Mesuximide) is an orally active succinimide-derived antiepileptic agent. Methsuximide interacts with cytochrome P-450, increases the level of hepatic microsomal cytochrome P-450, and inhibits or competes with the cytochrome P-450 CYP 2C9/10 subtype. Methsuximide can be used in epilepsy-related research .
Cat. No.: HY-179327
CAS No.: 1404073-15-9
Target:
Research Areas:
N-(Hexanoyloxy)succinimide-MMAE is a conjugate of the ADC drug toxin molecule and the linker, containing a degradable PEG linker and the toxin molecule MMAE (HY-15162) .
Cat. No.: HY-135623
CAS No.: 22855-57-8
Target:
Research Areas:
Brosuximide is a succinimide-type antiepileptic agent .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
